TIDMMAC1
RNS Number : 6391S
Marwyn Acquisition Company I Ltd
18 March 2021
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT
FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,
DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA,
CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF
THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE
UNLAWFUL TO DO SO.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMATION,
OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE
OR DISPOSE OF ANY SECURITIES IN MARWYN ACQUISITION COMPANY I
LIMITED OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS
ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS
OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN
RESPECT OF MARWYN ACQUISITION COMPANY I LIMITED .
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF THE UK VERSION OF EU REGULATION 596/2014 WHICH
FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL)
ACT 2018, AS AMED ("MAR").
LEI: 254900WYO35S1T334A28
Marwyn Acquisition Company I Limited
(to be renamed AdvancedAdvT Limited) (the "Company")
Placing and subscriptions to raise GBP130 million
Marwyn Acquisition Company I Limited, a vehicle seeking mid-cap
acquisition opportunities in the software sector, is pleased to
announce a placing (the "Placing") of 94.8 million new ordinary
shares of no par value in the Company ("Ordinary Shares") to be
issued at GBP1 per share (the "Placing Price") and subscriptions by
each of Marwyn Asset Management Limited (a related party of the
Company through common directors), Vin Murria OBE and other direct
investors for, in aggregate, 35.2 million Ordinary Shares (the
"Subscription Shares") at the Placing Price (the "Subscriptions"
and together with the Placing the "Fundraising") to raise a total
of GBP130 million in order to pursue its stated acquisition
strategy. The new Ordinary Shares issued pursuant to the
Fundraising are expected to be admitted to the standard segment of
the Official List and to trading on the London Stock Exchange's
Main Market at 8.00 a.m. on 23 March 2021 ("Admission").
Highlights
-- The Fundraising raised gross proceeds of GBP130 million
(approximately GBP128.5 million net of expenses)
-- Placing of 94.8 million new Ordinary Shares at GBP1 per share (the "Placing Shares")
-- Vin Murria OBE (Chairman) has agreed to subscribe for 17.5
million Ordinary Shares at GBP1 per share alongside investors
participating in the Placing (the "Placees"), and on Admission will
hold 13.1% of the total issued Ordinary Shares
-- Marwyn Asset Management Limited has agreed to subscribe for
17.5 million Ordinary Shares at GBP1 per share alongside the
Placees, and on Admission (following the automatic conversion of
its existing 2,500,000 A shares of no par value in the Company into
2,500,000 Ordinary Shares on Admission), will hold 15.4% of the
total issued Ordinary Shares
-- Marwyn Asset Management Limited has agreed to waive its
rights to its 2,500,000 Class A Warrants conditional upon
Admission
-- Gavin Hugill will join the Board as Chief Operating Officer with effect from 12 April 2021
-- Karen Chandler will join the Board as a Non-Executive Director on Admission
-- Mark Brangstrup Watts will step down from the Board as a Non-Executive Director on Admission
-- N+1 Singer will be appointed as the Company's sole broker with effect from Admission
-- On Admission, the Company is expected to be renamed
AdvancedAdvT Limited, with a new LSE ticker (ADVT) and website (
www.advancedadvt.com )
Vin Murria OBE (Chairman), commented: "We are delighted to see
such significant investor support for our strategy to capitalise on
the opportunities in the software sector, and we look forward to
deploying the capital to buy and grow an attractive platform
acquisition. We thank our investors for their support and backing .
"
The Company expects to publish a prospectus relating to the
admission of the Placing Shares and the Subscription Shares to the
standard listing segment of the Official List of the UK Listing
Authority and to trading on the main market for listed securities
of the London Stock Exchange (the "Prospectus") today following
approval by the FCA in accordance with the Prospectus Rules.
The Prospectus will, once published, be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
Once published, copies of the Prospectus will be available on
the Company's website at
www.marwynac1.com/investors/shareholder-documents subject to
applicable securities law, and free of charge during normal
business hours at 11 Buckingham Street, London, WC2N 6DF.
Further information on the Fundraising is set out in the
Prospectus.
PLACING STATISTICS
Number of existing Ordinary
Shares 700,000
Placing Price GBP1.00 per
Ordinary Share
----------------
Number of Placing Shares 94,800,000
----------------
Number of Subscription Shares 35,200,000
----------------
Enlarged ordinary share capital
in issue following the issue
of the Placing Shares and the
Subscription Shares 133,200,000
----------------
Percentage of enlarged Ordinary
Share capital represented by
the Placing Shares and the Subscription
Shares 97.6%
----------------
Gross proceeds of the Fundraising GBP 130,000,000
----------------
Proceeds of the Fundraising GBP 128,500,000
receivable by the Company (after
deduction of transaction costs)
----------------
The Company will invest the proceeds of the Fundraising
receivable by the Company (after deduction of transaction costs)
upon receipt in its subsidiary. The Company's subsidiary is a
related party of the Company due to its minority interests being
held by other related parties to the Company.
Directors and Proposed Directors
Below is a summary of the terms of new or updated service
agreements or letters of appointment with the directors and
proposed directors.
Vin Murria OBE (Chairman) - On 31 December 2020, the Company
entered into a letter of appointment with Vin Murria OBE, pursuant
to which she was appointed by the Company as non-executive
chairman. Pursuant to her letter of appointment, Vin is entitled to
an annual fee of GBP50,000 for her services as non-executive
chairman. Vin's appointment as a non-executive chairman may be
terminated upon 12 months' prior written notice. On 18 March 2021,
Vin entered into a side letter pursuant to which she agreed to
waive her annual fee from Admission until completion of the first
acquisition by the Company (or by any subsidiary thereof) of an
interest in an operating company or business ( "Acquisition" )
.
Gavin Hugill (Chief Operating Officer) - On 5 February 2021, the
Company entered into a service agreement with Gavin Hugill,
pursuant to which he was appointed by the Company as Chief
Operating Officer with effect from 12 April 2021. Pursuant to his
service agreement, Gavin is entitled to receive an annual salary of
GBP140,000 per annum, along with an annual bonus of such amount, at
such intervals and subject to such conditions as the remuneration
committee appointed by the Board shall in its sole discretion
determine, up to a maximum amount per annum of 30 per cent. of
Gavin's annual salary from time to time. The service agreement may
be terminated by either: (i) the Company or (ii) Gavin, by giving
not less than 6 months' written notice to the other party. Gavin's
service agreement contains a restrictive covenant limiting his
ability to compete with the Company for a 12 month period following
his resignation or termination from employment with the Company.
Gavin is entitled to a pension contribution equal to up to 5 per
cent. of his basic monthly salary, together with other benefits
commensurate with his position and duties.
Karen Chandler (Non-Executive Director) - On 18 March 2021,
Karen Chandler entered into a letter of appointment with the
Company pursuant to which, with effect from Admission, she will be
appointed by the Company as a non-executive director. Pursuant to
her letter of appointment, Karen is entitled to an annual fee of
GBP50,000 for her services as non-executive director. Karen's
appointment as non-executive director may be terminated upon three
months' written notice.
Mark Brangstrup Watts (Non-Executive Director) - On 5 November
2020, Mark Brangstrup Watts entered into a letter of appointment
with the Company pursuant to which he was appointed by the Company
as a non-executive director. Mark does not receive any fees at the
date of this Announcement. Although Mark's letter of appointment
contemplates an initial term of 24 months, he has agreed to resign
as a non-executive director with effect from Admission.
James Corsellis (Non-Executive Director) - On 5 November 2020,
James Corsellis entered into a letter of appointment with the
Company pursuant to which he was appointed by the Company as a
non-executive director. James Corsellis does not receive any fees
at the date of this Announcement, however, with effect from
completion of the first Acquisition he will be entitled to a fee of
GBP50,000 per annum. Following an initial term of 24 months, his
appointment as a non-executive director may be terminated upon 12
months' prior written notice.
Incentive Scheme Allocation
The Company's subsidiary, MAC I (BVI) Limited, has issued
redeemable A1 ordinary shares with a par value of GBP0.01 each ( "
Incentive Shares") to each of Vin Murria OBE, Karen Chandler and
Gavin Hugill (together, the "Management"). Following such
issuances, Management will be entitled to 15 per cent. of the
aggregate 20 per cent. of the growth in value of the Company (as
described in the Company's prospectus dated 30 November 2020 (the
"Prospectus")) which the Incentive Shares may deliver, and Marwyn
Long Term Incentive LP will be entitled to the remaining 5 per
cent.
In addition to the vesting conditions described in the
Prospectus, members of Management have agreed to lock-in periods,
leaver provisions and clawback provisions in relation to the
Incentive Shares they have acquired.
Each of Vin Murria OBE, Karen Chandler and Gavin Hugill has
agreed that their Incentive Shares will vest on a straight line
basis over 3 years from the date of completion of the Acquisition,
save on an exit event when the Incentive Shares will vest in full.
If they are deemed a good leaver, they will keep their vested
Incentive Shares, but otherwise they will lose all of the Incentive
Shares upon departure from the group. Either the Ordinary Shares
received upon exercise of the Incentive Shares (which is subject to
the redemption conditions having being met) and/or the remaining
Incentive Shares held by the individual may be clawed back if the
individual commits: (i) gross misconduct, (ii) fraud (iii) a
criminal act, or (iv) a material breach of any post termination
covenants or restrictions in their contract with the Company (if
applicable), in each case as determined by the Directors in their
absolute discretion; or if the Company materially restates the
audited consolidated accounts of the group (excluding for any
reason of change in accounting practice or accounting standards)
and the remuneration committee of the Company (acting in good
faith) concludes that, had such audited consolidated accounts been
correct at the time of exchange of such Incentive Shares, the
individual would not have received the full payment to which he or
she was owed (or the full number of Ordinary Shares he or she was
issued). In such circumstances, it is also possible for the
remuneration committee to require the individual to pay to the
Company or MAC I (BVI) Limited an amount equal to any cash received
by the individual received in exchange for some or all of his or
her Incentive Shares together with the net proceeds of the sale of
any securities received by him or her (i.e. through a distribution
in specie) less any tax paid or payable.
All holders of the Incentive Shares at the date of this
announcement have agreed that if any one of them exchanges some or
all of his or her Incentive Shares for an allotment of Ordinary
Shares, he or she shall not be permitted to enter into any
agreement to give effect to any transfer of the Ordinary Shares so
allotted at any time during the period of 12 months and one day
following the date of such allotment save in certain limited
circumstances.
In addition, on 18 March 2021, Vin Murria OBE subscribed for a
Sponsor Share in the Company with the equivalent rights to that
held by Marwyn (as described in the Prospectus).
Marwyn Capital Corporate Finance Agreement
On 18 March 2021, the Company and Marwyn Capital LLP ("Marwyn
Capital") agreed to amend the letter dated 5 November 2020 from
Marwyn Capital to the Company relating to Marwyn Capital's
engagement to carry out various corporate services to the Company
(the "Engagement Letter") . Under the terms of the side letter to
the Engagement Letter (the "Side Letter"), Marwyn Capital continues
to be appointed to provide ongoing advice in relation but not
limited to the following: corporate finance, research and analysis,
strategic development, forecasting and modelling, equity capital
markets, debt and equity fundraising, overall project management,
negotiation and bid documentation, but the fees have been reduced
in certain circumstances. Under the terms of the Side Letter,
Marwyn Capital is entitled to a retainer of GBP10,000 per month
which will reduce to GBP0 per month following Admission, save where
agreed otherwise. Marwyn Capital will continue to provide certain
accounting and administration services on an arm's length time and
cost basis. Any further fee revisions will be determined as and
when required (i.e. as part of an Acquisition and will be subject
to related party rules). In addition, as before, the Company may
also agree to pay a customary corporate finance fee to Marwyn
Capital in connection with an Acquisition.
Change of name, ticker and website
With effect from Admission, the Company will be renamed
AdvancedAdvT Limited, with a new LSE ticker (ADVT) and website (
www.advancedadvt.com ).
Change of broker
The Company has appointed Nplus1 Singer Capital Markets Limited
as its sole broker, with effect from Admission.
Enquiries:
Company Secretary
Antoinette Vanderpuije - 020 7004 2700
Marwyn Acquisition Company I Limited, 11 Buckingham Street,
London, WC2N 6DF
KK Advisory Ltd - Placing Agent
Kam Bansil - 020 7039 1901
Nplus1 Singer Capital Markets Limited - Broker 020 7496 3000
Phil Davies
Iqra Amin
Finsbury - PR Adviser
Rollo Head 07768 994 987
Chris Sibbald 07855 955 531
WH Ireland - Corporate Broker 020 7220 1666
Harry Ansell
Katy Mitchell
Further information on the Company can be found on its website
at www.MarwynAC1.com , which with effect from Admission will be
www.advancedadvt.com ). Neither the content of the Company's
website, nor the content on any website accessible from hyperlinks
on its website or any other website, is incorporated into, or forms
part of, this announcement nor, unless previously published by
means of a recognised information service, should any such content
be relied upon in reaching a decision as to whether or not to
acquire, continue to hold, or dispose of, securities in the
Company.
Listing Rule 9.6.13R Disclosure
Karen Chandler currently holds or has held the following
directorships in the past five years:
Director Current Directorships Past Directorships
Karen Louise The Cardiff Property Plc Pacific Petroleum Holdings
Chandler Plc
Aged 48
------------------------- ---------------------------
Gavin John Hugill (aged 44) is currently not a director of a
publicly quoted company nor has he been a director of a publicly
quoted company in the past five years.
There are no further details which would be required to be
disclosed under FCA's Listing Rule 9.6.13R in respect of the
appointments of Gavin Hugill and Karen Chandler.
IMPORTANT NOTICES
This Announcement has been prepared by, and is the sole
responsibility of, the Directors of Marwyn Acquisition Company I
Limited.
This Announcement is an advertisement and does not constitute a
prospectus relating to the Company and does not constitute, or form
part of, any offer or invitation to sell or issue, or any
solicitation of any offer to purchase or subscribe for, any shares
in the Company in any jurisdiction nor shall it, or any part of it,
or the fact of its distribution, form the basis of, or be relied on
in connection with or act as any inducement to enter into, any
contract therefor. Investors should not make any decision to
purchase, subscribe for, otherwise acquire, sell or otherwise
dispose of any Ordinary Shares referred to in this Announcement
except on the basis of the information contained in the Prospectus
published by the Company. Recipients of this Announcement who are
considering acquiring Ordinary Shares are reminded that any such
acquisition must be made only on the basis of the information
contained in the Prospectus which may be different from the
information contained in this Announcement.
The Placing Shares have not been, nor will they be, registered
under the US Securities Act of 1933, as amended (the "Securities
Act") or with any securities regulatory authority of any state or
other jurisdiction of the United States or under the applicable
securities laws of Australia, Canada, Japan, or South Africa.
Subject to certain exceptions, the Ordinary Shares may not be
offered or sold in the United States, Australia, Canada, Guernsey,
Jersey, Japan, Hong Kong Special Administrative Region of the
People's Republic of China or Switzerland or to or for the account
or benefit of any national, resident or citizen of Australia,
Canada, Guernsey, Jersey, Japan, Hong Kong Special Administrative
Region of the People's Republic of China or Switzerland or any
person located in the United States. The Fundraising and the
distribution of this Announcement in other jurisdictions may be
restricted by law and the persons into whose possession this
Announcement comes should inform themselves about, and observe, any
such restrictions.
Cautionary statements
This Announcement may contain and the Company may make verbal
statements containing "forward-looking statements" with respect to
certain of the Company's plans and its current goals and
expectations relating to its future financial condition,
performance, strategic initiatives, objectives and results.
Forward-looking statements sometimes use words such as "aim",
"anticipate", "target", "expect", "estimate", "intend", "plan",
"goal", "believe", "seek", "may", "could", "outlook" or other words
of similar meaning or the negative thereof. By their nature, all
forward-looking statements involve risk and uncertainty because
they relate to future events and circumstances which are beyond the
control of the Company. As a result, the actual future financial
condition, performance and results of the Company may differ
materially from the plans, goals and expectations set forth in any
forward-looking statements. Any forward-looking statements made in
this Announcement by or on behalf of the Company speak only as of
the date they are made. The information contained in this
Announcement is subject to change without notice and except as
required by
applicable law or regulation, the Company expressly disclaims
any obligation or undertaking to publish any updates or revisions
to any forward-looking statements contained in this Announcement to
reflect any changes in the Company's expectations with regard
thereto or any changes in events, conditions or circumstances on
which any such statements are based.
Statements contained in this Announcement regarding past trends
or activities should not be taken as representation that such
trends or activities will continue in the future. You should not
place undue reliance on forward-looking statements, which speak
only as of the date of this Announcement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEZZGMFZNZGMZZ
(END) Dow Jones Newswires
March 18, 2021 03:00 ET (07:00 GMT)
Marwyn Acquisition Compa... (LSE:MAC1)
Historical Stock Chart
From Jan 2025 to Feb 2025
Marwyn Acquisition Compa... (LSE:MAC1)
Historical Stock Chart
From Feb 2024 to Feb 2025